tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

EVMN Stock Latest News

Evommune: Buy Rating Driven by Upcoming Phase II Readouts and Broad Inflammatory Disease Pipeline Potential
RatingsEvommune: Buy Rating Driven by Upcoming Phase II Readouts and Broad Inflammatory Disease Pipeline Potential
8d ago
EVMN
Evommune initiated with a Strong Buy at Raymond James
PremiumThe Fly
Evommune initiated with a Strong Buy at Raymond James
9d ago
EVMN
Evommune initiated with a Strong Buy at Raymond James
PremiumThe Fly
Evommune initiated with a Strong Buy at Raymond James
9d ago
EVMN
Evommune’s EVO756 Trial Targets High-Need Urticaria Market: What Investors Should Watch
PremiumCompany Announcements
Evommune’s EVO756 Trial Targets High-Need Urticaria Market: What Investors Should Watch
10d ago
EVMN
Evommune participates in a conference call with William Blair
PremiumThe Fly
Evommune participates in a conference call with William Blair
10d ago
EVMN
Evommune initiated with a Buy at H.C. Wainwright
PremiumThe FlyEvommune initiated with a Buy at H.C. Wainwright
11d ago
EVMN
3 ‘Strong Buy’ Stocks to Buy Now,12/30/2025, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Now,12/30/2025, According to Top Analysts
17d ago
VIR
EVMN
Evommune: Multiple 2026 Phase II Readouts and Novel Immunology Mechanisms Drive Compelling Buy-Rated Risk‑Reward
Premium
Ratings
Evommune: Multiple 2026 Phase II Readouts and Novel Immunology Mechanisms Drive Compelling Buy-Rated Risk‑Reward
18d ago
EVMN
Buy Rating for Evommune, Inc. Driven by EVO756’s Promising Phase II Trial Potential
PremiumRatings
Buy Rating for Evommune, Inc. Driven by EVO756’s Promising Phase II Trial Potential
1M ago
EVMN
Evommune, Inc.: Promising Pipeline and Strategic Trials Drive Buy Rating
PremiumRatings
Evommune, Inc.: Promising Pipeline and Strategic Trials Drive Buy Rating
1M ago
EVMN
Closing Bell Movers: Broadcom down 5%, Lululemon gains 10%
PremiumThe Fly
Closing Bell Movers: Broadcom down 5%, Lululemon gains 10%
1M ago
NX
RH
Evommune reports Q3 EPS ($8.07) vs ($10.47) last year
PremiumThe Fly
Evommune reports Q3 EPS ($8.07) vs ($10.47) last year
1M ago
EVMN
Carvana initiated, Zscaler downgraded: Wall Street’s top analyst calls
PremiumThe FlyCarvana initiated, Zscaler downgraded: Wall Street’s top analyst calls
2M ago
ZS
CCI
Evommune initiated with an Outperform at Leerink
Premium
The Fly
Evommune initiated with an Outperform at Leerink
2M ago
EVMN
Evommune initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Evommune initiated with an Overweight at Cantor Fitzgerald
2M ago
EVMN
Evommune initiated with an Outperform at Evercore ISI
PremiumThe Fly
Evommune initiated with an Outperform at Evercore ISI
2M ago
EVMN
Evommune initiated with an Outperform at William Blair
PremiumThe Fly
Evommune initiated with an Outperform at William Blair
2M ago
EVMN
Promising Outlook for Evommune’s EVO756: Buy Rating Backed by Strong Data and Market Potential
PremiumRatings
Promising Outlook for Evommune’s EVO756: Buy Rating Backed by Strong Data and Market Potential
2M ago
EVMN
Evommune initiated with an Overweight at Morgan Stanley
PremiumThe Fly
Evommune initiated with an Overweight at Morgan Stanley
2M ago
EVMN
Promising Future for Evommune, Inc. in Inflammatory and Immunology Markets: Buy Rating Justified by Strong Pipeline and Experienced Leadership
PremiumRatingsPromising Future for Evommune, Inc. in Inflammatory and Immunology Markets: Buy Rating Justified by Strong Pipeline and Experienced Leadership
2M ago
EVMN
Opening Day: DNA test maker BillionToOne raises $314M in IPO
Premium
The Fly
Opening Day: DNA test maker BillionToOne raises $314M in IPO
2M ago
HCI
SEV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >